Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Immunol Lett. 2017 Oct 3;191:47–54. doi: 10.1016/j.imlet.2017.08.024

Figure 7.

Figure 7

Increased td-TGF-β allows tumor growth under high immune pressure, with later growth suppression and eradication.

CT26-neo or CT26-TGF-β cells were implanted (106/mouse) in the right flank of allogeneic C57B/6 mice and early tumor establishment was observed only in CT26-TGF-β and not in CT26-neo mice (n=5 per group). However, tumors were eradicated by day 21.